You may view this page as a pdf document   This document is available in .pdf format. If you would like to view this document as an Adobe Acrobat file, please click the image to the left. Please click here to get Adobe Acrobat Reader.

Refereed Publications

1. Ratcliffe M A, Dawson A A and Walker L G (1995). Eysenck Personality Inventory L-scores in patients with Hodgkin's disease and non-Hodgkin's lymphoma. Psycho-Oncology, 4, 39-45.



2. Walker L G and Eremin O (1995). Psychoneuroimmunology: new fad or the fifth therapeutic modality? American Journal of Surgery, 170, 2-4 (Invited Editorial).



3. Walker L G and Eremin O (1996). Psychological assessment and intervention: future prospects for women with breast cancer. Seminars in Surgical Oncology, 12, 76-83.



4. Johnson V C, Walker L G, Whiting P H Heys S D and Eremin O (1996). Can relaxation training and hypnotherapy modify the immune response to acute stress, and is hypnotisability relevant? Contemporary Hypnosis, 13, 100-108.



5. Alexander D A and Walker L G (1996). The perceived impact of police work on police officer's spouses and their families. Stress Medicine, 12, 239-246.



6. Walker L G (1996). Communication skills: when, not if, to teach. European Journal of Cancer, 32A, 1457-1459 (Invited Editorial).



7. Walker L G (1996). Behavioural oncology: psychological aspects of treating and understanding malignant disease. European Journal of Surgical Oncology, 22, 546-550.



8. Walker L G (1996). Psychological and psychiatric aspects of gynaecological cancer. In: D E Lolis (ed.), Obstetrics and Gynaecology. Parazianos, Athens (Chapter 19, pp 377-387).



9. Walker L G, Wesnes K A, Heys S D, Walker M B, Lolley J and Eremin O (1996). The cognitive effects of recombinant interleukin-2 (rIL-2) therapy: a controlled clinical trial using computerised assessments. European Journal of Cancer, 32A, 2275-2283.



10. Wesnes K A, Walker M B, Heys S D, White L, Warren R, Walker L G and Eremin O (1997). What does a weekend 'on call' in a surgical ward do to cognitive performance and mood? British Journal of Surgery, 84, 493-495.



11. Heys S D, Walker L G and Eremin O (1997). The value of peri-operative nutritional support in the sick patient. Proceedings of the Nutrition Society, 56, 443-457.



12. Langlois N, Walker L G, Eremin O and Heys S D (1997). Expression of growth factor receptors are not prognostic indicators in young patients with colorectal cancer. Journal of the Royal College of Surgeons of Edinburgh, 42, 98-101.



13. Fox H, Walker L G, Heys S D, Ah-See A K, and Eremin O (1997). Are patients with mastalgia anxious, and does relaxation therapy help? The Breast, 6, 138-142.



14. Walker L G, Walker M B, Heys, S D, Lolley J, Wesnes K and Eremin O (1997). The psychological and psychiatric effects of rIL-2: a controlled clinical trial. Psycho-Oncology. 6, 290-301.



15. MR Breast Screening Advisory Group (1997). National study of MRI screening for women at genetic risk of breast cancer. The Lancet, July 5th. (Also on http://www.thelancet.com/lancet/ writing/writing4.html).



16. Twelves CJ, Thomson CS, Young J and Gould A for the Scottish Breast Cancer Focus Group and the Scottish Cancer Therapy Network (1998). Entry into clinical trials in breast cancer: the importance of specialist teams. European Journal of Cancer, 34, 1004-1007.



17. Twelves CJ, Thomson CS, Gould A and Dewar J for the Scottish Breast Cancer Focus Group and the Scottish Cancer Therapy Network (1998). Variation in the survival of women with breast cancer in Scotland. British Journal of Cancer, 78, 566-571.



18. Walker L G (1998). Hypnosis and cancer: host defences, quality of life and survival. Contemporary Hypnosis, 15, 34-39.



19. Walker L G, Köhler C, Heys S D and Eremin O (1998). Psychosocial aspects of cancer in the elderly. European Journal of Surgical Oncology, 24, 375-378.



20. Heys S D, Ogston K, Miller I, Hutcheon A W, Walker L G, Sarkar T K, Dewar J, Ah-See A K, and Eremin O (1998). Potentiation of the response to chemotherapy in patients with breast cancer by dietary supplementation with L-arginine: results of a randomised controlled trial. International Journal of Oncology, 12, 221-225.



21. Heys S D, Walker L G and Eremin O (1998). Serum albumin: an independent prognostic indicator in colorectal cancer. Journal of the Royal College of Surgeons of Edinburgh, 43, 163-168.



22. Heys S D, Langlois N, Smith I C, Walker L G and Eremin O (1998). NM23 gene product expression does not predict lymph node metastasis or survival in young patients with colorectal cancer. Oncology Reports, 5, 735-739.



23. Eltahir A, Heys S D, Hutcheon A W, Sarkar T K, Walker L G, Ah-See A K and Eremin O (1998). Treatment of large and locally advanced breast cancers using neoadjuvant chemotherapy. American Journal of Surgery, 175, 127-132.



24. Gruzelier J, Clow A, Evans P, Lazar I and Walker L (1998). Mind-body influences on immunity: lateralised control, stress, individual difference predictors and prophylaxis. Annals of the New York Academy of Science, 851, 487-494.



25. Gilbert F J, Cordiner C M, Affleck I R, Hood D B, Mathieson D and Walker L G (1998). Breast screening: the psychological costs of false positive recall in women with and without a history of breast cancer. European Journal of Cancer, 34, 2010-2014.



26. Heys SD, Ogston KN, Simpson WG, Walker LG, Hutcheon AW, Sarkar TK, and Eremin O (1998). Acute phase proteins in patients with large and locally advanced breast cancer treated with neo-adjuvant chemotherapy: response and survival. International Journal of Oncology, 13, 589-594.



27. Stewart A, Porter R W, Primrose W R, Walker L G and Reid D M (1999). Cervical and trochanteric hip fractures: bone mass and other parameters. Clinical Rheumatology, 18, 201-206.



28. Walker L G, Walker M B, Heys S D, Ogston K, Miller I, Hutcheon A W, Sarkar TK and Eremin O (1999). The psychological, clinical and pathological effects of relaxation training and imagery during primary chemotherapy. British Journal of Cancer, 80, 262-268.



29. Heys S D, Walker L G, Smith I and Eremin O (1999). Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Annals of Surgery, 229, 467-477. (Special Feature).



30. Walker L G and Anderson J (1999). Testing complementary and alternative medicine within a research protocol. European Journal of Cancer, 35, 1614-1618. (Invited contribution for Special Edition edited by M Slevin and J Mossman).



31. Walker L G, Heys SD, Walker M B, Ogston K, Miller I, Hutcheon A W, Sarkar T K, Ah-See A K and Eremin O (1999). Psychological factors can predict the response to primary chemotherapy in women with locally advanced breast cancer. European Journal of Cancer, 35, 1783-1788.



32. Stewart A, Primrose WR, Walker LG, Reid DM (1999). Risk factors associated with increased falls in a hip fracture population. Gerontology, 45, 233.



33. Walker L G (1999). Psychological interventions, host defences and survival. Advances in Mind-Body Medicine, 15, 236-281. (Invited comment on Greer S ‘Mind-Body Research in Psycho Oncology.’)



34. Stewart A, Walker L G, Porter R W, Reid D M and Primrose W (1999). Predicting a second hip fracture. Journal of Clinical Densitometry, 2, 363-370.



35. Walker L G, Heys S D and Eremin O (1999). Surviving cancer: does the fighting spirit help? Journal of Psychosomatic Research. 47, 497-503. (Invited Editorial.)



36. Klein S, Kitchener H C, Tracy D and Walker LG (2000). The effects of cancer patient participation in teaching communication skills to medical undergraduates: a follow-up evaluation. European Journal of Cancer, 36, 273-81.



37. Brown J, Coulthard A, Dixon AK, Dixon JM, Easton DF, Eeles RA, Evans DG, Gilbert FG, Hayes C, Jenkins JP, Leach MO, Moss SM, Padhani AP, Pointon LJ, Ponder BA, Sloane JP, Turnbull LW, Walker LG, Warren RM, Watson W (2000). Rationale for magnetic resonance imaging screening in women at high genetic risk of breast cancer. The Breast 9, 72-77.



38. Brown J, Coulthard A, Dixon AK, Dixon JM, Easton DF, Eeles RA, Evans DG, Gilbert FG, Hayes C, Jenkins JP, Leach MO, Moss SM, Padhani AP, Pointon LJ, Ponder BA, Sloane JP, Turnbull LW, Walker LG, Warren RM, Watson W (2000). Protocol for magnetic resonance imaging screening in women at high genetic risk of breast cancer. The Breast, 9 78-82.



39. Warren R, Hayes C and the Advisory Group of the UK study of screening for breast cancer (MARIBS) (2000). Localisation of breast lesions shown only on MRI - a review of the UK study of MRI screening for breast cancer. British Journal of Radiology, 73, 123-132.



40. Walker L G (2000). Psychoneuroimmunology. Cancer Topics, 11, 17-19.



41. Alexander D A and Walker L G (2000). Is my stress greater than yours? A comparison of police officers and firemen. International Journal of Police Science and Management, 2, 303-312.



42. Brown J, Buckley D, Coulthard A, Dixon A K, Dixon, J M, Easton D F, Eeles R A, Evans D G R, Gilbert F J, Graves M, Hayes C, Jenkins J P R, Jones A P, Keevil S F, Leach M O, Liney G P, Moss S M, Padhani A R, Parker G J M, Pointon L J, Ponder B A J, Redpath T, Sloane J P, Turnbull L W, Walker L G and WarrenR M L (2000). Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. Magnetic Resonance Imaging, 18, 765-776.



43. Chen R, Dick F, Semple S, Seaton A and Walker L G. (2001) Solvent exposure and personality. Occupational and Environmental Medicine, 58, 14-18.



44. Eagles JM and Walker LG (2001). A comparison of real patients, suimulated patients and videotaped interviews in teaching medical students about alcohol misuse. Medical Teacher, 23, 490-493.



45. Harding L, Walker L G, Lloyd D and Duffty P (2001). A controlled study of children born at gestation 28 weeks or less: psychological characteristics at seven to ten years of age. Health Bulletin, 59, 81-90.



46. Heap M, Alden P, Brown R J, Naish P, Oakley D A, Wagstaff G and Walker L G (2001). The Nature of Hypnosis. A report prepared by a Working Party at the request of the Professional Affairs Board of the British Psychological Society. British Psychological Society, Leicester. (ISBN: 1 85433 355 0).



47. Anderson J and Walker L G (2002). Psychological aspects of MRI breast screening in women at high risk of breast cancer. In R Warren and A Coultard (Eds). Breast MRI in Practice. Martin Dunitz, London. ISBN 1-84184-137-4.



48. Smith I C, Heys S D, Hutcheon A W, Payne S, Miller I D, Gilbert F J, Ah-See A K, Eremin O, Walker L G, Walker M B, Sarkar T K, Ogston K N (2002). Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. Journal of Clinical Oncology, 20, 1456-1466.



49. Anderson J and Walker L G (2002). Psychological factors and cancer progression: involvement of behavioural pathways. The Psychoimmunology of Cancer (2nd Edition). Chapter 7. In C E Lewis, R O’Brien and J Barraclough (Eds). Oxford University Press, Oxford. ISBN: 0192630601.



50. Degenhard A, Tanner C, Hayes C, Hawkes DJ, Leach MO on behalf of the UK MRI Breast Screening Study (2002). Comparison between radiological and artificial neural network diagnosis in clinical screening. Physiological Measurement, 23, 727-39.



51. Dick F, Semple S, Osborne A, Soutar A, Seaton A, Cherrie J W, Walker L G, Haites N. (2002) Organic solvent exposure, genes, and risk of cognitive impairment. Quarterly Journal of Medicine, 95, 379-387.



52. Heys SD, Hutcheon AW, Sarkar TK, Ogston KN, Miller ID, Payne S, Smith I, Walker LG, Eremin O. (2002) Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial. Clinical Breast Cancer, Oct 3, Suppl 2:S69-74.



53. Dagenhard A, Tanner C, Hayes C, Hawkes D J, Leach M O and the UK MRI Breast Screening Study (2002). Comparison between radiological and artificial neural network diagnosis in clinical screening. Physiological Measurement, 23, 727-739.



54. Warren R M L, Pointon L, Caines R, Hayes C, Thompson D, Leach M O and the UK MRI Breast Screening Study (MARIBS) (2002). What is the recall rate of breast MRI when used for screening asymptomatic women at high risk? Magnetic Resonance Imaging, 20, 557-565.



55. Walker L G, Walker M B and Sharp D M (2003). The organisation of psychosocial support within palliative care. In M Lloyd-Williams (Ed). Psychosocial Issues in Palliative Care. Oxford University Press, Oxford. ISBN 0-19-851540-5.



56. Leach M O, Eeles R A, Turnbull L W, Dixon A K, Brown J, Hoff RJ, Coulthard A, Dixon J M, Easton D F, Evans D G, Gilbert F J, Hawnaur J, Hayes C, Kessar P, Lakhani S, Liney G, Moss S M, Padhani A P, Pointon L J, Sydenham M, Walker L G et al. (2003). The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS). Journal of Experimental Clinical Cancer Research, 21, 107-14.



57. Keith D, Walker M B, Walker L G, Heys S D, Sarkar T K, Hutcheon A W and Eremin O (2003). Women who wish breast reconstruction: characteristics, fears and hopes. Plastic & Reconstructive Surgery, 111, 1051-1056.



58. Walker L G, Walker M B and Sharp D M (2003). Psychosocial oncology services for women with breast cancer. Trends in Urology, Gynaecology and Sexual Health, 8, 25-32.



59. Walker L G. (2004). Hypnotherapeutic insights and interventions: a cancer odyssey. Contemporary Hypnosis, 21, 35-45.



60. Walker L G, Lind M J, Sharp D M, Walker M B and Walker A A (2004). Palliative Care. Written Evidence, Hull and East Yorkshire Hospitals NHS Trust. House of Commons. HC 454-II.



61. Walker L G (2004). Integrative Tumor Board: recurrent lymphoma. Biopsychosocial perspective. Integrative Cancer Therapies, 3, 250-254.



62. Walker L G, Green V, Greenman J, Walker A A and Sharp D M (2005). PNI and Chronic Malignant Disease: Cancer. In Irwin M and Vedhara V (Eds) Human Psychoneuroimmunology (PNI). Oxford University Press.



63. MARIBS Study Group (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). The Lancet, 365, 1769-1778.



64. Gray N M, Sharp L, Cotton S, Aves M, Philips Z, Russell I, Walker L G, Whynes D, Little J (2005). Developing a questionnaire to measure the psychosocial impact of an abnormal cervical smear result and its subsequent management: the TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) trial. Quality of Life Research,14, 1553-1562.



65. Iwuagwu O, Stanley P, Platt A, Drew P, Walker L (2006). Effects of bilateral breast reduction on anxiety and depression: Results of a prospective randomised trial. Scandinavian Journal of Plastic Reconstruction Surgery and Hand Surgery, 40, 19-23.



66. Iwuagwu O C, Walker L G, Stanley P W, Hart N B, Platt A J, Drew P J (2006). Randomized clinical trial examining psychosocial and quality of life benefits of bilateral breast reduction surgery. British Journal of Surgery, 93, 291-4.



67. Gray N M, Sharp L, Cotton S C, Masson L F, Little J, Walker L G, Avis M, Philips Z, Russell I and Whynes D (2006). Psychological effects of a low-grade abnormal smear test result: anxiety and associated factors. British Journal of Cancer, 94, 253-262.



68. Klaber Moffett J, Jackson D A, Gardiner E D, Torgerson D J, Coulton S, Eaton S, Mooney, Pickering, C, Green, AJ and Walker L G (2006). Comparison of ‘McKenzie’ physical therapy treatment vs a brief physiotherapy intervention: A randomised clinical trial of neck pain and back pain patients in primary care. Rheumatology, Oct 24; [Epub ahead of print].



69. Griebsch I, Brown J, Boggis C,Dixon A, Dixon M, Easton D, Eeles R, Evans DG, Gilbert FJ, Hawnaur J, Kessar P, Lakhani1 SR,Moss SM, Nerurkar A, PadhaniAR, Pointon L, Potterton J, Thompson D, Turnbull LW, Walker LG, Warren R, Leach MO for the UK Magnetic Resonance Imaging in Breast Screening (MARIBS) Study Group (2006). Cost-effectiveness of contrast enhanced magnetic resonance imaging versus X-ray mammography of women at a high familial risk of breast cancer. British Journal of Cancer, 95, 801-810.



70. Sharp L, Cotton SC, Alexander L, WilliamS E, Gray N M, Reid JM on behalf of the TOMBOLA group (2006). Reasons for participation and non-participation in a randomised controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears). Clinical Trials, 3, 431-442.



71. Sharma, A, Sharp DM, Walker LG and Monson JRT (2007). Predictors of early postoperative quality of life after elective resection for colorectal cancer. Annals of Surgical Oncology, 14, 3435-3342.



72. Sharma A, Walker AA, Sharp DM, Monson JRT and Walker L G (2007). Psychosocial factors and quality of life in colorectal cancer. The Surgeon, 5, 344-354.



73. Walker LG, Walker AA, Walker MB and Sharp DM (2007). Relaxation, visualisation, and hypnotherapy. In Barraclough J. Enhancing Cancer Care: Complementary, Expressive and Supportive Therapies in Oncology. Oxford, Oxford University Press.



74. Sharma A, Sharp D M, Monson J R T and Walker L G (2008). Patient personality predicts postoperative stay after colorectal cancer resection. Colorectal Disease, 10, 151-156.



75. Sharma A, Sharp D, Walker L G and Monson J R T (2008). Stress and burnout among colorectal surgeons and colorectal nurse specialists working in the NHS. Colorectal Disease10, 397-406.



76. Sharma A, Sharp D M, Walker L G and Monson J R T (2008). Stress and burnout among colorectal and vascular surgical consultants working in the NHS. Psycho Oncology,17, 570-576.



77. Sharma A, Sharp DM, Walker LG and Monson JRT (2008). Colorectal MDTs: the team’s perspective. Colorectal Disease, 10, 63-68.



78. Thomas R, Williams M, Marshall C, Allerton R and Walker L (2008). Switching to letrozole or exemestane improves hot flushes, mood and quality of life in tamoxifen intolerant women. British Journal of Cancer, 98, 1494-1499.



79. Sharma A, Greenman J, Sharp D M, Walker L G, Monson J R T (2008). Vascular endothelial growth factor and psychosocial factors in colorectal cancer. Psycho-Oncology 17, 66-73.

Conference Abstracts

1. Klein S, Kitchener H and Walker L G (1995). Does cancer patient participation in a communication skills programme enhance the performance of medical undergraduates? British Gynaecological Cancer Society Abstracts.



2. Gilbert F J, Cordiner C M, Affleck I R, Deans H, Hood D B, Mathieson D, Ah–See A K, Eremin O and Walker L G (1995). How anxiogenic is recall following breast screening, and does a family history of breast cancer make a difference? Psycho-Oncology, 4, 88.



3. Stewart A, Primrose W R, Porter R W, Walker L G and Reid D M (1995). Do fallers have reduced bone mass? Bone, 16 (1), Suppl, 1195.



4. Walker L G, Ratcliffe M A and Dawson A A (1995). Does personality affect survival in lymphoma patients? Psycho-Oncology, 4, 98.



5. Klein S, Kitchener H C and Walker L G (1995). Does cancer patient participation in communication skills training enhance the performance of medical undergraduates? Psycho-Oncology, 4, 90.



6. Deehan D J, Heys S D, Walker L G and Eremin O (1995). Serum albumin: an independent prognostic indicator for survival in patients with colorectal cancer. British Journal of Surgery, 82, 961.



7. Millar L L, Peterson K A, Walker L G, Whiting P W, Gough D B, Friend J A R and Eremin O (1995). Does emotional suppression and depressed mood predict immunosuppression in patients with lung disease? European Journal of Surgical Oncology, 21, 698.



8. Wesnes K A, Walker M B, Heys S D, White L, Warren R, Walker L G and Eremin O (1996). What does a weekend 'on call' in a surgical ward do to cognitive performance and mood? British Journal of Surgery, 83, (Suppl. 1), 37.



9. Walker L G, Miller I, Walker M B, Simpson E, Ogston K, Segar A, Heys S D, Ah-See A K, Hutcheon A W, Sarkar T K and Eremin O (1996). Immunological effects of relaxation training and guided imagery in women with locally advanced breast cancer. Psycho-Oncology, 5(3) (suppl), 16.
   
   
10. 10. Walker L G, Walker M B, Simpson E, Ogston K, Segar A, Heys S D, Ah-See A K, Hutcheon A W, Sarkar T K and Eremin O (1996). Relaxation training and imagery enhance quality of life during chemotherapy for breast cancer. Psycho-Oncology, 5(3) (suppl), 36.



11. Walker L G, Millar L L, Peterson K A, Friend J A R, Gough D B, Whiting P W and Eremin O (1996). Psychological factors predict immunosuppression in patients with lung cancer and benign lung disease. Psycho-Oncology, 5 (3) (suppl), 69.



12. Walker L G, Walker M B, Simpson E, Fielden S, Ogston K, Segar A, Heys S D, Ah-See A K, Hutcheon A W, Sarkar T K and Eremin O (1996). Do psychological factors predict clinical and pathological response to chemotherapy? Psycho-Oncology 5(3) (suppl), 69.



13. Walker L G, Walker M B, Simpson E, Ogston K, Segar A, Heys S D, Ah-See A K, Hutcheon A W, Sarkar T K and Eremin O (1996). Relaxation training and imagery enhance quality of life during chemotherapy for breast cancer. British Journal of Surgery, 83, 1647.



14. Walker L G, Walker M B, Simpson E, Ogston K, Segar A, Heys S D, Ah-See A K, Hutcheon A W, Sarkar T K and Eremin O (1996). The effects of relaxation training and visualisation on quality of life during chemotherapy for breast cancer: a controlled trial. Proceedings, Eighth Overseas Meeting, Royal College of Surgeons of Edinburgh and the College of Surgeons of Hong Kong, Hong Kong, p 123.



15. Eremin O, Walker L G, Walker M B, Simpson E, Fielden S, Ogston K, Segar A, Heys S D, Ah-See A K, Hutcheon A W, Sarkar T K and Eremin O (1996). A controlled clinical trial of the effects of relaxation training and guided imagery in women with locally advanced breast cancer. Proceedings, Eighth Overseas Meeting, Royal College of Surgeons of Edinburgh and the College of Surgeons of Hong Kong, Hong Kong, p 123.



16. Walker L G, Peterson K, Millar L L, Friend J A R, Gough D B, Whiting P H and Eremin O (1996). Psychological factors and immunosuppression in patients with lung cancer and benign lung disease. Proceedings, Eighth Overseas Meeting, Royal College of Surgeons of Edinburgh and the College of Surgeons of Hong Kong, Hong Kong, p 174.



17. Heys S D, Walker L G and Eremin O (1996). The value of nutritional support in the peri-operative period: an analysis of randomised controlled trials. Proceedings, Eighth Overseas Meeting, Royal College of Surgeons of Edinburgh and the College of Surgeons of Hong Kong, Hong Kong, p 183.



18. Heys S D, Ogston K, Walker L G and Eremin O (1996). Pre-treatment serum albumin: an independent indicator of survival in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy. Proceedings, Eighth Overseas Meeting, Royal College of Surgeons of Edinburgh and the College of Surgeons of Hong Kong, Hong Kong, p 187.



19. Ogston K, Heys S D, Walker L G and Eremin O, and the Aberdeen and Dundee Breast Group (1996). Controlled trial of l-arginine and chemotherapy versus chemotherapy alone in patients with large or locally advanced breast cancers. British Journal of Surgery, 83, 149.



20. Walker L G, de Silva D and Haites N (1996). Psychological effects of individualised breast cancer risk counselling. Psycho-Oncology, 5, 350.



21. Klein S, Kitchener H C, Hutcheon A W and Walker L G (1996). Media coverage of cancer: a pilot study of the much-neglected influence on adjustment to cancer and its treatment. Psycho-Oncology, 5, 355.



22. Lolley J, Eremin O and Walker L G (1996). Multimodal therapy: a novel intervention for patients with cancer. Psycho-Oncology, 5, 356.



23. Millar L L, Peterson K A, Friend J A R, Gough D B, Walker L G, Whiting P W and Eremin O (1996). Do psychological factors predict immunosuppression in patients with lung cancer and benign lung disease? Psycho-Oncology, 5, 356.



24. Walker L G (1996). Psychoneuroimmunotherapy: a flash in the pan? Psycho-Oncology, 5, 360.



25. Walker L G, Wesnes, K A, Walker M B, Heys S D, White L, Warren R and Eremin O (1996). What does a weekend 'on call' in a surgical unit do to cognitive performance and mood? Psycho-Oncology, 5, 360.



26. Stewart A, Primrose W R, Walker L G, Porter R W and Reid D M (1996). Ultrasound and DXA in prediction of second hip fractures. Osteoporosis International, 6, suppl. 1, p 156.



27. Stewart A, Primrose W R, Walker L G, Reid D M and Porter R W (1996). Falls in an elderly population with hip fractures. Current Research in Osteoporosis and Bone Mineral Measurement, IV. (Eds E F G Ring, D M Elvins and A K Bhalla). British Institute of Radiology, p 5.



28. Langlois N E I, Smith I C, Skinner L, Walker L G, Eremin O and Heys S D (1996). Growth factor receptor expression is not a prognostic indicator in young patients with colorectal cancer. British Journal of Surgery, 83, 699-700.



29. Ogston K, Heys S D, Walker L G and Eremin O (1996). A controlled trial of l-arginine and chemotherapy versus chemotherapy alone in patients with large or locally advanced breast cancers. European Journal of Surgical Oncology, 22, 559.



30. Smith I C, Walker L G, Eremin and Heys S D (1997). Value of nutritional support in the peri-operative period: an analysis of randomised controlled trials. British Journal of Surgery, 84, 719.



31. Ogston K, Simpson W, Heys S D, Walker L G, Hutcheon A W and Eremin O (1997). Pre-treatment acute phase proteins: independent indicators of survival in patients with locally advanced breast cancer treated with neo-adjuvant chemotherapy. British Journal of Surgery, 84, 723.



32. Walker L G, Walker M B, Simpson E, Fielden S, Ogston K, Segar A, Heys S D, Ah-See A K, Hutcheon A W and Eremin O (1997). Guided imagery and relaxation therapy can modify host defences in women receiving treatment for locally advanced breast cancer. British Journal of Surgery, 84, suppl 1, 31.



33. Smith I C, Walker L G, Eremin and Heys S D (1997). The value of nutritional support in the peri-operative period: an analysis of randomised controlled trials. British Journal of Surgery, 84, suppl 1, 41.



34. Walker L G, Ogston K, Heys S D, Ah-See A K, Hutcheon A W and Eremin O (1997). Psychological factors predict response to neoadjuvant chemotherapy in women with locally advanced breast cancer. British Journal of Surgery, 84, suppl 1, 46.



35. Köhler C R D, Heys S D, Hutcheon A W, Walker L G and Eremin O (1997). Do sociodemographic factors influence the decision to give chemotherapy to women with breast cancer? British Journal of Surgery, 84, suppl 1, 46.



36. Walker L G (1997). Do psychological factors prolong survival in patients with cancer? Proceedings, British Psychological Society, 5, 150.



37. Klein S, Kitchener H C and Walker L G (1997). What are the long-term effects of the participation of patients with cancer in teaching communication skills to medical undergraduates? Psycho-Oncology, 6, 235.



38. Köhler C R D, Walker L G, Heys S D, Ah-See A K, Hutcheon A W and Eremin O (1997). Do sociodemographic factors influence the decision to give chemotherapy to women with breast cancer? Psycho-Oncology, 6, 236.



39. Walker L G, Heys S D, Ogston K, Walker M B, Miller I, Hutcheon A W, Ah-See A K and Eremin O (1997). Psychological factors predict response to neo-adjuvant chemotherapy in women with locally advanced breast cancer. Psycho-Oncology, 6, 242-243.



40. Walker L G, Walker M B, Simpson E, Fielden S, Ogston K, Segar A, Heys S D, Ah-See A K, Hutcheon A W and Eremin O (1997). Relaxation therapy and guided imagery modify host defences in women receiving treatment for locally advanced breast cancer. Psycho-Oncology, 6, 243.



41. Walker M B, Walker L G, Simpson E, Ogston K, Segar A, Heys S D, Ah-See A K, Hutcheon A W, Sarkar T K and Eremin O (1997). Relaxation training and imagery improve mood in women receiving treatment for locally advanced breast cancer. Psycho-Oncology, 6, 243-244.



42. Walker L G, Heys S D and Eremin O (1997). Do psychological interventions prolong survival in patients with cancer and, if so, how? Proceedings, Stress of Life Congress, Budapest, Hungary.



43. Walker L G (1997). Do psychological interventions prolong survival in patients with cancer and, if so, how? Contemporary Hypnosis, 14, 250-251.



44. Walker L G (1997). Primary chemotherapy in large and locally advanced breast cancer. Proceedings, International Breast Cancer Meeting, Nottingham.



45. Walker L G, Walker M B, Simpson E, Ogston O, Segar A Heys S D, Ah-See A K, Hutcheon A W, Sarkar T and Eremin O (1997). Relaxation and imagery improve mood in women receiving treatment for locally advanced breast cancer. European Journal of Surgical Oncology, 23, 99.



46. Walker L G, Ogston K, Walker M B, Heys S D, Ah-See A K, Hutcheon A W and Eremin O (1996). Psychological factors predict response to neoadjuvant chemotherapy in women with locally advanced breast cancer. European Journal of Surgical Oncology, 23, 94.



47. Ogston K, Walker M B, Simpson E, Fielden S, Segar A, Heys S D, Ah-See A K, Hutcheon A W, Sarkar T K, Walker L G and Eremin O (1997). A controlled clinical trial of the immunological effects of relaxation training and guided imagery in women with locally advanced breast cancer. European Journal of Surgical Oncology, 23, 372.



48. Walker L G, Walker M B, Ogston O, Heys S D, Ah-See A K, Hutcheon A W, Sarkar T K and Eremin O (1997). Who will practice relaxation and guided imagery? European Journal of Surgical Oncology, 23, 599.



49. Ogston K, Simpson W, Heys S D, Walker L G Hutcheon A W and Eremin O (1997). Pre-treatment acute phase proteins: independent indicators of survival in patients with locally advanced breast cancer. European Journal of Surgical Oncology, 23, 379.



50. Walker L G, Walker M B, Ogston O, Heys S D, Ah-See A K, Hutcheon A W, Sarkar T K and Eremin O (1997). Can relaxation and guided imagery alter the Type C personality? European Journal of Surgical Oncology, 23, 587.



51. Walker L G (1998). Cancer-related stress: psychoneuroimmunological aspects. Psycho-Oncology, 7, Number 4 (Suppl), 71.



52. Smith I C, Anderson J, Walker L G, Walker M B, Heys S D, Sarkar T K, Hutcheon A W, Ah-See A K, Eggleton S P H and Eremin O (1998). Primary chemotherapy and breast cancer: sequential changes in various components of quality of life. Annals of Oncology, 9, suppl 4, 16.



53. Walker L G, Anderson J, Heys S D, Walker M B, Smith I C, Hutcheon A W, Sarkar T K, Ah-See A K, Eggleton S P H and Eremin O (1998). Quality of life during primary chemotherapy: randomised, controlled trial of CVAP and docetaxel. Annals of Oncology, 9, suppl 4, 16.



54. Eremin O, Smith I C, Hutcheon A W, Heys S D, Ah-See A K, Sarkar T K, Miller I, Payne S, Eggleton S P H and Walker L G (1998). Chemotherapy in breast cancer: enhanced response with docetaxel. Annals of Oncology, 9, suppl 4, 13.



55. Miller I D, Payne S, , Smith I C, Walker L G, Hutcheon A W, Ah-See A K, Sarkar T K, Eremin O, Eggleton P and Heys S D (1998). HER-2 positivity and ER negativity predicts the complete pathological response of breastcancers treated with primary docetaxel. Proceedings of the 6th Nottingham International Breast Meeting.



56. A W Hutcheon, Smith I C, Heys S D, Ah-See A K, Walker L G, Miller I D, Payne S, Gilbert FJ Sarkar T K, Eggleton S P H and Eremin O (1998). Chemotherapy in breast cancer: enhanced response with docetaxel. Proceedings of the 6th Nottingham International Breast Meeting.



57. Walker L G, Walker M B, Ogston O, Heys S D, Ah-See A K, Hutcheon A W, Sarkar T K and Eremin O (1998). Can the Type C personality be modified by relaxation and guided imagery? Psycho-Oncology, 7, 66-67.



58. Walker L G, Walker M B, Ogston O, Heys S D, Ah-See A K, Hutcheon A W, Sarkar T K and Eremin O (1998). Which patients will practice relaxation and guided imagery? Psycho-Oncology, 7, 66.



59. Smith I C, Ross J A, Hutcheon A W, Ogston K N, Gilbert F J, Eremin O, Walker L G and Heys S D (1998). Randomised trial of the effect of hyperbaric oxygen on response to primary chemotherapy for breast cancer. European Journal of Surgical Oncology, 24, 619.



60. Smith I C, Walker M B, Anderson J, Walker L G, Heys S D, Sarkar T K, Hutcheon A W, Ah-See A K, Eggleton S P H, and Eremin O (1998). Sequential changes in quality of life during primary chemotherapy for breast cancer. European Journal of Surgical Oncology, 24, 627.



61. Anderson J, Walker L G, Heys S D, Walker M B, Smith I C, Hutcheon A W, Sarkar T K, Ah-See A K, Eggleton S P H, and Eremin O (1998). Docetaxel versus CVAP: quality of life during primary chemotherapy for breast cancer. European Journal of Surgical Oncology, 24, 626.



62. Smith I C, Walker L G, Hutcheon A W, Heys S D, Ah-See A K, Anderson J, Walker M B, Sarkar T K, Miller I, Payne S, Eggleton S P H and Eremin O (1998). Chemotherapy for breast cancer: enhanced response with docetaxel. European Journal of Surgical Oncology, 24, 616.



63. Stewart A, Primrose WR, Walker LG and Reid DM (1999). Risk factors associated with increased falls in a hip fracture population. Gerontology, 45, 223.



64. Walker M B, Anderson J, Whitaker T, Simpson E, Walker L G, Smith I C, Heys S D, Sarkar, Hutcheon A W, Ah-See A K, Eggleton S P H and Eremin O. (1999). When is quality of life worst during primary chemotherapy for breast cancer? Psycho-Oncology, 8, 12.



65. Walker L G, Walker M B, Anderson J, Whittaker T, E Simpson, Smith I C, Heys S D, Hutcheon A W, Sarkar T K, Ah-See A K, Eggleton S P H and Eremin O. (1999). Is quality of life better during primary CVAP or docetaxel chemotherapy? Psycho-Oncology, 8, 12.



66. Keith D J W, Walker M B, Heys S D, Smith I C, Ah-See A K, Walker L G and Eremin O. (1999). Women who wish breast reconstruction: characteristics, fears and hopes. Psycho-Oncology, 8, 7.



67. Black E, Walker L G, Heys S D, Ah-See A K and Eremin O. (1999) Do cancer prone personality characteristics predict immunosuppression in patients with early breast cancer and mastalgia? Psycho-Oncology, 8, 2.



68. Walker L G, Walker M B, Ogston O, Heys S D, Ah-See A K, Hutcheon A W, Sarkar T K and Eremin O (1999). Can relaxation and guided imagery alter the Type C personality? Proceedings of the Joint Meeting of the Royal Colleges of Physicians and Surgeons of Edinburgh with the College of Medicine of South Africa, Cape Town.



69. Walker L G, Smith I C, Walker M B, Anderson J, Heys S D, Sarkar T K, Hutcheon A W, Ah-See A K, Eggleton S P H, and Eremin O (1999). Sequential changes in quality of life during primary chemotherapy for breast cancer. Proceedings of the Joint Meeting of the Royal Colleges of Physicians and Surgeons of Edinburgh with the College of Medicine of South Africa, Cape Town.



70. Anderson J, Walker L G, Heys S D, Walker M B, Smith I C, Hutcheon A W, Sarkar T K, Ah-See A K, Eggleton S P H, and Eremin O (1999). Docetaxel versus CVAP: quality of life during primary chemotherapy for breast cancer. Proceedings of the Joint Meeting of the Royal Colleges of Physicians and Surgeons of Edinburgh with the College of Medicine of South Africa, Cape Town.



71. Walker L G (1999). Psychological interventions and the immune system in patients with cancer. Proceedings of the Joint Meeting of the Royal College of Psychiatrists and the British Psychosocial Oncology Society, and the British Journal of Psychiatry.



72. Miller I D, Payne S, Walker L G, Smith I C, Hutcheon A W, Heys S D, Ah-See A K, Sarkar T K, Eggleton P and Eremin O (1999). Primary chemotherapy for breast cancer: biological predictors of pathological response. ASCO Abtracts #2378.



73. Eremin O, Walker L G, Smith I C, Heys S D, Ah-See A K, Anderson J, Walker M B, Sarkar T K, Miller I D, Payne S, Eggleton S P H and A W Hutcheon (1999). Chemotherapy in breast cancer: enhanced response with docetaxel. ASCO Abstracts #271.



74. Eremin O, Walker L G, Smith I C, Heys S D, Ah-See A K, Anderson J, Walker M B, Sarkar T K, Miller I D, Payne S, Eggleton S P H and A W Hutcheon (1999). Chemotherapy in breast cancer: enhanced response with docetaxel. ECCO 10 Abstracts.



75. Higgins C A, Cruickshank M, Walker L G and Anderson J (1999). The impact of gynaecological cancer the marital and sexual relationships of patients and their partners. British Journal of Obstetrics and Gynaecology, 1999, 106, 994.



76. Walker L G (2000). What does a pathological diagnosis do to the patient?. Proceedings of the Pathological Society of Great Britain and Ireland, Nottingham.



77. Walker MB, Walker LG, Simpson E, Hutcheon AW, Sarkar TK, Heys SD and Eremin O (2000). Do relaxation and guided imagery improve survival in women with locally advanced breast cancer? Psycho Oncology, 9, 355.



78. Higgins C A, Cruickshank M, Walker L G and Anderson J (2000). The impact of gynaecological cancer the marital and sexual relationships of patients and their partners. Journal of Obstetrics and Gynaecology, 20, 108.



79. Walker L G, Ratcliffe M A and Dawson A A. (2000). Relaxation and hypnotherapy: long term effects on the survival of patients with lymphoma. Psycho Oncology, 9, 355-356.



80. Anderson J, Walker MB and Walker LG (2000). Distress and concerns of the partners of patients with breast cancer who receive primary chemotherapy. Psycho Oncology, 9, 357.



81. Anderson J, Walker MB and Walker LG (2000). The Mood Rating Scale: a brief, acceptable, reliable and valid state measure of normal mood. Psycho Oncology, 9, 359.



82. Anderson J, Leach M O and Walker LG on behalf of the MRC Study Advisory Group (2000). MRI screening for breast cancer in women at high genetic risk: protocol for a psychosocial assessment of the relative effects of MRM and XRM. Psycho Oncology, 9, 445-457.



83. Walker L G (2001). Surviving cancer: does the fighting spirit mater?. Proceedings of the British Psychological Society, 9, 13.



84. Ogston K N, Smith I C, Walker L G, Hutcheon A W, Gilbert F, Needham G, Payne S, Miller I, Ah-see A K, Eremin O and Heys S D (in press). Is mammography or ultrasonography the best method of assessing residual tumour size following neoadjuvant chemotherapy for breast cancer? European Journal of Surgical Oncology.



85. Smith I C, Heys S D, Hutcheon A W, Sarkar T K, Walker L G, Miller I and Eremin O (in press). Prognostic significance of lymph node metastasis after neoadjuvant chemotherapy for locally advanced breast cancer. European Journal of Surgical Oncology.



86. Smith I C, Walker L G, Eremin O and Heys S D (in press). Targeted nutritional support in the peri-operative period reduces the risk of infective complications: a meta-analysis of clinical trials. European Journal of Surgical Oncology.



87. Smith I C, Heys S D, Köhler, C R D, Hutcheon A W, Walker L G and Eremin O (in press). Age influences the decision to give chemotherapy to women with breast cancer. European Journal of Surgical Oncology.



88. Leach MO and the UK MR Breast Advisory Steering Group (in press). The UK national study for screening women at high risk of breast cancer: progress and initial results. European Radiology.



89. Anderson J, Leach M O and Walker L G (2001). Annual screening for women with a family history of breast cancer: the relative impact of magnetic resonance and X-ray mammography. Psycho-Oncology, 10, 264.



90. Walker L G, Walker M B, Simpson E, Heys S, Anderson J, Sharp D M, Hutcheon A W, Sarker T K, Ah-See A K and Eremin O (2001). Coping with cancer: state or trait? Psycho-Oncology, 10, 273.



91. Eremin O, Walker M B, Simpson E, , Hutcheon A W, Sarker T K, Heys S D, Ah-See A K and Walker L G (2001). Changes in the number of natural killer (CD 56+) cells, but not relaxation and guided imagery, predict survival in breast cancer. Psycho-Oncology, 10, 264.



92. Walker MB, Walker LG, Heys SD and Eremin O (2001). Relaxation and guided imagery: do they improve survival in women with locally advanced breast cancer? Proceedings of the British Psychological Society, 9, 269.



93. Walker L G, Ratcliffe M A and Dawson A A. (2001). A long-term follow up study of the effects of relaxation and hypnotherapy on the survival of patients with lymphoma. Proceedings of the British Psychological Society, 9, 269.



94. Walker L G, Walker M B, , Anderson J and Sharp DM (2001). Coping with cancer: state or trait? Proceedings of the British Psychological Society, 9, 269.



95. Anderson J, Walker MB and Walker LG (2001). Distress and concerns of the partners of patients with breast cancer who receive primary chemotherapy. Proceedings of the British Psychological Society, 9, 153.



96. Anderson J, Leach M O and Walker L G (2001). Annual screening for women with a family history of breast cancer: the relative impact of magnetic resonance and X-ray mammography. Proceedings of the British Psychological Society, 9, 154.



97. Anderson J, Walker MB and Walker LG (2001). The Mood Rating Scale: a brief, acceptable, reliable and valid state measure of normal mood. Proceedings of the British Psychological Society, 9, 154.



98. Sharp DM, Walker MB and Walker LG (2001). Psychosocial support for cancer patients: an integrated, multidisciplinary team approach. Proceedings of the Clinical Excellence 2001 Annual Conference and Exhbition. National Institute for Clinical Excellence, London.



99. Walker L G, Walker M B, Anderson J, Heys S D, Smith I C, Hutcheon A W, Sarkar T K, Ah See AK and Eremin O (2002). Quality of life during primary chemotherapy with continuing cyclophosophamide, vincristine, adriamycin and prednisolone (CVAP) versus sequential docetaxel: a randomised trial. Proceedings of the 25th San Antonio Breast Cancer Symposium. (http://www.abstracts-on-line.com/abstracts/BCS/)



100. Frizelle D, Sharp DM, Davis L, Spyrou G, Garrido A, Ali R, Walker L and V Ramakrishnan V (2002). Satisfaction with breast reconstruction following mastectomy Proceedings of the British Psychological Society, 10, 67-68.



101. Sharp DM, Walker MB and Walker LG (2002). Equity of use of psychosocial support services for cancer patients. Proceedings of the British Psychological Society, 10, 99.



102. Walker LG, Walker MB and Sharp DM (2002). A comparison of the effects of chemotherapy and radiotherapy on quality of life. Proceedings of the British Psychological Society, 10, 106.



103. Gray N, Sharp L, Cotton SC, Little J, Avis M, Philips Z, Walker LG, Duncan I (2002). Women’s experiences of having an abnormal smear result: qualitative analyses from TOMBOLA. Journal of Obstetrics and Gynaecology, 22, 108.



104. Frizelle D, Sharp DM, Davis L, Spyrou G, Garrido A, Ali R, Walker L and V Ramakrishnan V (2002). Patient satisfaction with immediate breast reconstruction in women undergoing mastectomy for breast cancer. Psycho-Oncology, 11, 550.



105. Sharp DM, Walker MB, Anderson J, Bateman J, Hope T, Hebblewhite C, and Walker LG (2002). Developing psychosocial support services for cancer patients: an integrated multidisciplinary team approach. Psycho-Oncology, 11, 555.



106. Gray N, Sharp L, Cotton S C, Little J, Avis M, Philips Z, Walker L G, Duncan I (2002). Women’s experiences of having an abnormal smear result: qualitative analyses from TOMBOLA. Journal of Obstetrics and Gynaecology, 22, 108.



107. Gray N, Sharp L, Avis M, Philips Z, Russell I, Walker L G (on behalf of the TOMBOLA group) (2002) Assessing psychosocial sequelae in TOMBOLA: design and preliminary results. Proceedings of the First Scottish Colposcopy Meeting, Stirling.



108. Heys SD, Hutcheon AW, Sarkar TK, Ogston KN, Miller ID, Payne S, Smith I, Walker LG, Eremin O (2002). Aberdeen Breast Group. Neoadjuvant docetaxel in breast cancer: 3-year survival results from Aberdeen trial. Clinical Breast Cancer, 3, S69–S74.



109. Walker L G, Walker M B, Anderson J, Sharp D M, Heys S D, Smith I C, Hutcheon A W, Sarkar T K, Eremin O. (2003). A comparison of the effects of chemotherapy and radiotherapy on quality of life. Psycho Oncology, 12, S143 (#252).



110. Walker L G, Frizelle, D J Spyrou G, Garrido A, Ali R, Ramakrishnan V , Sharp D M. (2003). Satisfaction with immediate cersus delayed reconstruction following mastectomy for breast cancer. Psycho Oncology, 12, S142 (#250).



111. Walker M B, Bateman J, C Hebblewhite, Hope T, Sharp D M and Walker L G (2003). How important is the type of clothes female nursing staff wear in a drop in centre, and what do patients, relatives and staff prefer? Psycho Oncology, 12 S141 (#248).



112. Walker L G, Walker M B, Anderson J, Sharp D M, Heys S D, Smith I C, Hutcheon A W, Sarkar T K, Eremin O. (2003). A randomised controlled trial of quality of life during primary chemotherapy with continuing cyclophosphamide, vincristine adriamycin and prednisolone (CVAP) versus sequential docetaxel: a randomised trial. Psycho Oncology, 12, S140 (#244).



113. Walker L G, Ratcliffe M A and Dawson A A. (2003). Relaxation and hypnotherapy improve long-term survival in patients with lymphoma. Psycho Oncology, 12, S155 (#299).



114. Walker M B, Frizelle D J, Bateman J, Hope T, Lines M, Ellwood K, Hebblewhite C, Walker LG and Sharp D M. (2003). An integrated multidisciplinary approach for psychosocial support services for cancer patients: eqity of use. Psycho Oncology, 12, S141-142 (#249).



115. Walker L G, Walker M B, Anderson J, Sharp D M, Heys S D, Smith I C, Hutcheon A W, Sarkar T K, Eremin O (2003). A comparison of the effects of chemotherapy and radiotherapy on quality of life. Proceedings of the 3rd International Conference on Psycho-Oncology, Graz. (Page 34).



116. Sharp D M, Walker M B, Frizelle D J, Bateman J, Hope T, Lines M, Ellwood K, Hebblewhite C, and Walker LG (2003). An integrated multidisciplinary approach for psychosocial support services for cancer patients: equity of use. Proceedings of the 3rd International Conference on Psycho-Oncology, Graz. (Page 25).



117. Walker L G, Sharp D M, Walker M B, Frizelle D J, Bateman J, Ellwood K, Hebblewhite C, Hope T, Lines M (2003). A unique oncology health service for patients with cancer and their families, Proceedings of the 8th European Forum, Bergen.



118. Walker L G (2003). What is the evidence? Proceedings of European Society of Medical and Surgical Oncology Summer Educational Conference, Edinburgh.



119. Walker L G (2003). Psychosocial research: the future. Proceedings of the conference to celebrate the 30th Anniversary of Breast Cancer Care, London.



120. Walker L G (2003). The mind, the body, the person. Proceedings of the Second Cavendish Centre National Conference, Sheffield.



121. Walker L G (2003). Psychobiological aspects of cancer. Proceedings of the British Psychological Society.



122. Walker L G (2003). Psychobiological aspects of cancer. Proceedings of the British Psychological Society, Ambleside.



123. Walker L G (2004) An integrated approach to developing psycho oncology services. Proceedings of the 11th International Conference of the Pan African Psych Oncology Society, Midrand, South Africa.



124. Walker M B, Bateman J, Ellwood K, Frizelle D J, Hebblewhite C, Hope T, Lines M, Sharp D M, Walker A A and Walker L G. (2004) Integrating psychosocial support services and promoting equity of use, Proceedings of the 11th International Conference of the Pan African Psych Oncology Society, Midrand, South Africa.



125. Walker L G (2004). Strategies for research in complementary medicine in cancer. Proceedings of the UICC 4th World Conference for Cancer Organisations, Dublin, Ireland.



126. Anderson J, Walker L G and Leach M O (2004). Magnetic resonance imaging: an acceptable way of screening women with a family history of breast cancer. Proceedings of the 27th Annual San Antonio Breast Cancer Symposium, San Antonio, USA.



127. Gray N, Sharp L, Cotton SC, Avis M, Phillips Z, Russell I, Walker L G and Whynes D (2004). Assessing the psychosocial impact of receiving an abnormal smearresult: Developing a study instrument and results of pilot work. Proceedings of the British Psychological Society, 12, 83.



128. Walker LG, Walker MB Walker A A and Sharp DM (2004). Complementary therapies in cancer care: a research experience from the UK. Complementary Therapies in Medicine, 12, 166.



129. Thomas RJ, Marshall CJ, Williams M, Walker LG. (2005). Does switching to letrozole improve hot flushes, mood and quality of life in tamoxifen intolerant patients? Proceedings of the the 28th Annual San Antonio Breast Cancer Symposium, San Antonio. (Abstract 2067).



130. Walker LG, Eremin JM, Vassanasiri W, Walker MB, El-Sheemy M, Jibril J, Valerio D, Cowley G, Clarke D, Kamal M, Thorpe G, Beer J, Wiseman J, Eremin O. (2005). Quality of life during three-weekly versus weekly neoadjuvant docetaxel: a randomised trial. Proceedings of the the 28th Annual San Antonio Breast Cancer Symposium, San Antonio. (Abstract 5064).



131. Alexandropoulou A, Green V L, Walker M B, Walker A A, Sharp D M, Walker L G, Greenman J. (2005). Endocrine and immune effects of reflexology and massage in women with early breast cancer. Proceedings of the 6th Meeting of the International Society of Neuroimmunomodulation, Athens.



132. Walker LG, Eremin JM, Vassanasiri W, Walker MB, El-Sheemy M, Jibril J, Valerio D, Cowley G, Clarke D, Kamal M, Thorpe G, Beer J, Wiseman J, Eremin O (2006). Quality of life during three-weekly versus weekly neoadjuvant docetaxel: a randomised trial. Psycho-Oncology, 15, S451.



133. Walker AA, Walker MB, Walker LG and Sharp DM (2006). What happens to anxiety and depression in women with early breast cancer accessing an integrated Oncology Health Service? Psycho-Oncology, 15, S452.



134. Walker AA, Walker MB, Greenman J, Sharp DM, and Walker LG (2006). Does reflexology improve quality of life in women who have undergone surgery for early breast carcinoma? Psycho-Oncology, 15, S137.



135. Sharp DM, Walker AA, Walker MB, Green V, Alexandropoulos A and Walker LG (2006). The psychoneuroimmunological effects of reflexology in women with early breast carcinoma. Psycho-Oncology, 15, S42-43.



136. Walker LG, Walker M B, Simpson E, Heys SD, Ogston K, Eremin O (2006).The psychoimmunological effects of relaxation and guided imagery in women with locally advanced breast carcinoma. Psycho-Oncology, 15, S43.



137. Sharma A, Sharp DM, Monson JRT and Walker LG (2006). Patient personality predicts postoperative stay after colorectal cancer resection. Psycho-Oncology, 15, S452.



138. Sharma A, Sharp DM, Monson JRT and Walker LG (2006). Stress and burnout among NHS surgeons in the United Kingdom. Psycho-Oncology, 15, S452.



139. Sharma A, Sharp DM, Monson JRT and Walker LG (2006). Is VEGF related to psychosocial factors in patients with colorectal cancer? Psycho-Oncology, 15, S407-408.



140. Sharma A, Sharp D M, Walker L G, Monson J R T (2006). Patient personality predicts postoperative stay after elective resection for colorectal cancer. Colorectal Disease, 8(Suppl. 2), 62.



141. Sharma A, Sharp D M, Walker L G, Monson J R T (2006). Predictors of postoperative quality of life in colorectal cancer patients. Colorectal Disease, 8 (Suppl. 2), 69.



142. Sharma A, Greenman J, Sharp D M, Walker L G, Monson J R T(2006). Colorectal cancer- survival differences due to quality of life factors- Is VEGF responsible. British Journal of Surgery, 93 (S1), 230.



143. Sharma A, Sharp D M, Walker L G, Monson J R T (2006). Can patient personality predict postoperative stay after colorectal cancer resection? British Journal of Surgery, 93 (S1), 230.



144. Sharma A, Greenman J, Sharp D M, Walker L G, Monson J R T (2006). Is VEGF related to psychosocial factors in patients with colorectal cancer? Journal of Surgical Research, 130, 321.



145. Sharma, A, Greenman J, Sharp DM, Monson JRT and Walker LG (2007). Is VEGF related to psychosocial factors in patients with colorectal cancer? Psycho Oncology, 16, 273.



146. Sharp DM, Walker AA, Walker MB and Walker LG (2007). A randomised controlled psychoimmunological trial of reflexology in women with early stage breast cancer. Psycho-Oncology, 16, 62.



147. Hutton J, Walker LG, Sharp DM and Leach MO on behalf of the MARIBS Advisory Group (In press). Magnetic Resonance Imaging: an acceptable way of screening women with a family history of breast cancer? Psycho-Oncology, 16, 265



148. Sharma, A, Sharp DM, Walker LG and Monson JRT (2007). Patient personality and the prediction of postoperative stay after colorectal cancer resection. Psycho-Oncology, 16, 273.



149. Sharma, A, Sharp DM, Monson JRT and Walker LG (2007). Stress and burnout among NHS surgeons in the United Kingdom. Psycho-Oncology, 16, 272.



150. Sharp DM, Walker AA, Walker MB and Walker LG (2007). Are high levels of clinically significant anxiety and depression inevitable in the sx months following the diagnosis of early breast cancer? Psycho-Oncology, 16, 272-273.



151. Walker AA, Shar DM,Walker MB, Wang M and Walker LG (2007). Which dispositional factors predict quality of life following surgery for early breast cancer? Psycho Oncology, 16, 9, S205.



152. Sharma A, Sharp DM, Monson JRT, and Walker LG (2007). Whose stress is greater than whose? Stress and burnout in Colorectal Surgeons, Vascular Surgeons and Colorectal Nurse Specialists working in the NHS. Psycho Oncology, 16, 9, S169.



153. Sharp DM, Bateman JS, Braid F, Frizelle DJ, Harrison S, Hebblewhite C, Hope T, Lines M, Walker MB and Walker LG (2007). Does integration of support services enhance equity of use? Psycho Oncology, 16, 9, S230.



154. Sharma A, Sharp DM, Monson JRT, and Walker LG (2007). Colorectal MDTs: the Team’s perspective. Psycho Oncology, 16, 9 S170.



155. Sharma A, Sharp DM, Monson JRT and Walker LG (In press). Stress and burnout among Colorectal Surgeons and Colorectal Nurse Specialists working in the NHS. Colorectal Disease.



156. Sharma A, Sharp DM, Monson JRT and Walker LG (In press). Stress and burnout among NHS surgeons in the United Kingdom. Colorectal Disease.



157. Sharma A, Greenman J, Sharp D M, Walker L G, Monson J R T (In press). Vascular Endothelial Growth Factor and psychosocial factors in colorectal cancer. Annals of Surgical Oncology.

© 2002-2008 AAWalker and LGWalker